ORIGINAL RESEARCH article

Front. Nutr.

Sec. Clinical Nutrition

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1588391

Prognostic Impact of Body Composition and Immune-nutritional Status in Oligometastatic NSCLC Patients Receiving Radiotherapy

Provisionally accepted
Zhifei  HuangZhifei Huang1Ziwen  GuoZiwen Guo1Bo  GaoBo Gao1Shun  LiShun Li1Yaner  YuYaner Yu2Shuangqiu  ZhuShuangqiu Zhu1Zelai  HeZelai He1Haiyan  ChenHaiyan Chen2*Hao  JiangHao Jiang1*
  • 1Bengbu Medical College, Bengbu, Anhui Province, China
  • 2Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

Background: Metabolic and nutritional status are recognized as prognostic and predictive biomarkers in cancer treatment. However, there is limited research on oligometastatic non-small cell lung cancer (NSCLC) patients undergoing radiotherapy.We aimed to explore the independent and synergistic effects of body composition and immune-nutritional status on survival outcomes in these patients.Methods: Patients with oligometastatic NSCLC who underwent radiotherapy between 2017 and 2022 were retrospectively included. The evaluated outcomes were overall survival (OS) and progression-free survival (PFS). The skeletal muscle index (SMI), subcutaneous fat index (SFI), and pericardial fat index (PFI) were obtained using computed tomography (CT) and normalized by height squared. Laboratory biomarkers were utilized to assess immune-nutritional status. Univariate chi-square tests and multivariate logistic regression analyses were employed to determine correlations between hematological parameters and body composition. We conducted K-M analyses, along with univariate and multivariate Cox regression analyses to evaluate survival outcomes.Results: 102 patients (mean age 61.44 years, 51 males [50%]) were included.Compared to non-responders, responders exhibited a significantly lower prevalence of sarcopenia (44.93% vs 55.07%, P=0.007) and demonstrated relatively better immune-nutritional scores. Logistic regression analyses revealed that a low Prognostic Nutritional Index (PNI) was a risk factor for SMI, SFI, and PFI.Multivariate Cox analyses revealed that C reactive protein-to-albumin ratio (CAR) (HR=0.26; 95% CI 0.11-0.61; P=0.002) and PFI (HR=2.73; 95% CI 1.06-7.01; P=0.037) were predictive factors for OS. CAR (HR=0.34, P=0.001) and SFI (HR=1.82, P=0.049) were independent prognostic markers for PFS. K-M analyses indicated that the group with high PNI and high SFI exhibited markedly improved OS and PFS, as well as the one with high PNI and without sarcopenia (P<0.001).Among oligometastatic NSCLC patients receiving radiotherapy, higher skeletal muscle and fat content, along with better immune-nutritional status, correlated with improved survival outcomes.

Keywords: Body Composition, immune-nutritional scores, Oligometastasis, NSCLC, radiotherapy 1.Introduction

Received: 05 Mar 2025; Accepted: 30 May 2025.

Copyright: © 2025 Huang, Guo, Gao, Li, Yu, Zhu, He, Chen and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Haiyan Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, Zhejiang Province, China
Hao Jiang, Bengbu Medical College, Bengbu, 233030, Anhui Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.